ESC Premium Access

Prognostic impact of admission hyperglycemia in acute coronary syndrome patients and its interaction with diabetes mellitus history and metabolic control.

Congress Presentation

About the speaker

Doctor Jose Pedro Alves Guimaraes

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)
0 follower

6 more presentations in this session

Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials

Speaker: Doctor R. Mehran (New York, US)


Diagnostic performance of quantitative flow ratio in diabetic and non-diabetic patients

Speaker: Mr J. Smit (Leiden, NL)


A clinical risk score to predict the presence of obstructive coronary artery disease in asymptomatic patients with type 2 diabetes

Speaker: Assistant Professor C. Kim (Uijungbu, KR)


Impact of glycated hemoglobin in diabetic patients with coronary artery disease undergoing surgery, angioplasty or clinical treatment in a very long-term follow-up

Speaker: Mr E. Martins (Sao Paulo, BR)


De-escalation of antiplatelet therapy after percutaneous coronary intervention in acute coronary syndrome patients: outcome of diabetics in the randomized TROPICAL-ACS trial

Speaker: Doctor R. Hein (Munich, DE)


Access the full session

Diabetes-associated coronary artery disease

Speakers: Doctor J. Alves Guimaraes, Doctor R. Mehran, Mr J. Smit, Assistant Professor C. Kim, Mr E. Martins...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb